KFP
NVO

KB Financial Partners’s Novo Nordisk NVO Stock Holding History

KB Financial Partners’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$1.02M Sell
11,230
-4
-0% -$352 0.29% 37
2023
Q2 		$909K Buy
11,234
+4,922
+78% +$402K 0.25% 44
2023
Q1 		$502K Sell
6,312
-386
-6% -$27.4K 0.15% 89
2022
Q4 		$453K Sell
6,698
-142
-2% -$8.32K 0.15% 101
2022
Q3 		$341K Buy
6,840
+1,544
+29% +$82.7K 0.12% 117
2022
Q2 		$295K Buy
+5,296
New +$294K 0.1% 126
2022
Q1 		– Sell
-44
Closed -$2K – 650
2021
Q4 		$2K Buy
+44
New +$2.38K ﹤0.01% 605

Other funds holding NVO

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

KB Financial Partners's NVO Position: Q3 2023 in Review

KB Financial Partners reduced its Novo Nordisk (NVO) stake by 0.04% in Q3 2023, selling an estimated $352 and leaving 11,230 shares worth $1.02M. The position accounts for 0.29% of the portfolio, ranked #37.

KB Financial Partners first reported a position in NVO in Q4 2021 and has held it in 7 quarters since. 1,307 funds tracked by Wall St. Rank hold NVO as of Q3 2023.

  • KB Financial Partners held 11,230 shares of Novo Nordisk worth $1.02M as of Q3 2023.
  • KB Financial Partners sold 4 Novo Nordisk shares in Q3 2023, an estimated $352.
  • Novo Nordisk made up 0.29% of KB Financial Partners's portfolio in Q3 2023, its #37 holding.
  • KB Financial Partners first reported a position in Novo Nordisk in Q4 2021 and has held it in 7 quarters since.
  • 1,307 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2023.

Based on KB Financial Partners's 13F filing for Q3 2023, filed 15 Nov 2023.